Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
Human SLC29A1 Protein expressed in Wheat germ - ABIN1320347
Greenhalf, Ghaneh, Neoptolemos, Palmer, Cox, Lamb, Garner, Campbell, Mackey, Costello, Moore, Valle, McDonald, Carter, Tebbutt, Goldstein, Shannon, Dervenis, Glimelius, Deakin, Charnley, Lacaine et al.: Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. ... in Journal of the National Cancer Institute 2014
FBW7 (show FBXW7 Proteins) promoted gemcitabine sensitivity via upregulation of equilibrative nucleoside transporter 1 (ENT1) at the protein level rather than the transcriptional level.
ENT1 is a prognostic marker for pT2 gallbladder cancer (GBC) patients.
FLT3 (show FLT3 Proteins) has a role in cytarabine transport by SLC29A1 in pediatric acute leukemia
rs760370 SNP cannot serve as predictor of response in chronic HCV patients treated with interferon (show IFNA Proteins) ribavirin therapy.
The combination of ENT1, MATE1 and OCT2 SNPs may serve as a predictive and prognostic marker in metastatic colorectal carcinoma patients treated with TAS (show MAP3K4 Proteins)-102.
CYR61 (show CYR61 Proteins) negatively regulates the nucleoside transporters hENT1 and hCNT3 (show SLC28A3 Proteins) in pancreatic ductal adenocarcinoma.
Chronic inhibition of ENT1 or by genetic removal of ENT1 enhanced the survival of R6/2 mice. Collectively, adenosine homeostasis and ENT1 expression are altered in Huntington's disease (HD). The inhibition of ENT1 can enhance extracellular adenosine level and be a potential therapeutic approach for treating HD.
Combined expression analyses of hENT1, TS, and DPD (show DPYD Proteins) may predict long-term outcomes in patients with borderline resectable pancreatic cancer after neoadjuvant chemoradiotherapy
studies describe 2 novel modes of action of ticagrelor, inhibition of platelet ENT1 and inverse agonism at the P2Y12R that contribute to its effective inhibition of platelet activation.
These findings suggest that ENT1 is regulated via receptor-dependent calcium-linked pathways resulting in an alteration of purine flux, which may modulate purinergic signaling and influence NA drug efficacy.
These pathways are consistent with previously reported behavioral and biochemical phenotypes that typify mice lacking ENT1. Moreover, we validated decreased expression of the SNARE (show VTI1B Proteins) complex protein VAMP1 (synaptobrevin-1 (show VAMP1 Proteins)) in the dHip as well as decreased expression of pro-dynorphin (PDYN (show PDYN Proteins)), neuroendocrine convertase (PCSK1 (show PCSK1 Proteins)), and Leu-Enkephalin (dynorphin-A (show PDYN Proteins)) in the nucleus accumbens
results establish Augustine as a new blood group (show DARC Proteins) system and place SLC29A1 as a new candidate gene for idiopathic disorders characterized with ectopic calcification/mineralization.
Findings demonstrate that ENT1 regulates GFAP (show GFAP Proteins) expression and possibly astrocyte function
ENT1-regulated adenosine signaling plays an essential role in lumbar spine and femur bone density
findings implicate ENT1 in liver protection from ischemia and reperfusion injury and suggest ENT inhibitors may be of benefit in the prevention or treatment of ischemic liver injury
This is the first report of a role for ENT1 in regulating the calcification of soft tissues. ENT1(-/-) mice may be a useful model for investigating pathogenesis and evaluating therapeutics for the prevention of mineralization in DISH and related disord
It was shown that the responsiveness of kidney tubules and glomeruli is significantly attenuated in the absence of ENT1, leading to changes of extracellular adenosine levels in the juxtaglomerular apparatus interstitium.
This study demonstrated that the A2AR (show ADORA2A Proteins) antagonist ZM241385 dampened protein kinase A activity-mediated signaling in the DMS and promoted excessive ethanol drinking in ENT1(+/+) mice
Perfusions without sodium drastically reduced the intestinal loss of ribavirin in both wild-type and Ent1(-/-) mice.
This gene is a member of the equilibrative nucleoside transporter family. The gene encodes a transmembrane glycoprotein that localizes to the plasma and mitochondrial membranes and mediates the cellular uptake of nucleosides from the surrounding medium. The protein is categorized as an equilibrative (as opposed to concentrative) transporter that is sensitive to inhibition by nitrobenzylthioinosine (NBMPR). Nucleoside transporters are required for nucleotide synthesis in cells that lack de novo nucleoside synthesis pathways, and are also necessary for the uptake of cytotoxic nucleosides used for cancer and viral chemotherapies. Multiple alternatively spliced variants, encoding the same protein, have been found for this gene.
equilibrative NBMPR-sensitive nucleoside transporter
, equilibrative nitrobenzylmercaptopurine riboside (NBMPR)-sensitive nucleoside transporter
, equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter
, equilibrative nucleoside transporter 1
, nucleoside transporter, es-type
, solute carrier family 29 (nucleoside transporters), member 1
, solute carrier family 29 member 1
, solute carrier family 29, member 1
, NBMPR-sensitive equilibrative nucleoside transporter
, equilibrative nucleoside transporter 1 variant delta 11